Drugs / Subunit Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT07854392 | Oct → Nov 2026 expected | influenza | Ab&B Bio-tech Co., Ltd.JS | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00559975 Comparator | Oct 2007 → May 2008 | influenza | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Subunit Influenza Vaccine | “A Phase IV Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults” NCT07854392 ↗ |
| Modality | Vaccine | “Subunit influenza vaccine” NCT00559975 ↗ |
| Route | Intramuscular | “one intramuscular injection of the study vaccine” NCT07854392 ↗ |